Abstract
The acquisition of simultaneous resistance to chemotherapeutic agents displaying a variety of chemical structures and different action mechanisms, a phenomenon known as multidrug resistance (MDR), is still the main obstacle in the treatment of cancer patients. Given the situation, hard work has focused on the identification and evaluation of potential modulators mainly the members of the …